UAE becomes first Middle Eastern country to receive vaccine for cervical cancer
The UAE recently became the first Middle Eastern nation to receive the newly discovered vaccine against cervical cancer.
Gardasil, which is distributed by Merck Sharp & Dohme, is now available in over 33 countries around the world, according to Khaleej Times and the Cancer Registry Program. Its approval in the UAE followed directives from the county’s Ministry of Health.
“We are proud to have placed the UAE on the map with leading countries such as the US, Australia and EU by approving Gardasil, the first breakthrough vaccine that prevents the cancer,” said Dr Wisam Haddadin, Franchise Manager, Gulf Region, Merck Sharp & Dohme.
Cervical cancer is primarily caused by HPV (Human Papilloma Virus). Approximately, 2.3 million women are currently diagnosed with cervical cancer worldwide and 800 women die because of cervical cancer every day. The annual average of reported cervical cancer cases in the UAE has tripled in 2005 compared with that from 1998 to 2004.
- Symposium Addresses New Data on Cervical Cancer Vaccination
- 150 Students Attend Cervical Cancer Awareness Seminar at Sharjah College
- Dubai Media Incorporated and Dubai World Trade Center Support ‘Everything I Can’ Cervical Cancer Awareness Campaign
- bioMérieux Brings a New Concept in Molecular Diagnostic Testing for the Prevention of Cervical Cancer
- Abu Dhabi Health Authority to Hold Educational Symposium